Copyright © 2023 Nudelman/ShutterstockRituximab was first approved by the FDA in 1997 for the treatment of CD20-positive B-cell non-Hodgkin’s lymphoma (NHL). Its approval marked a significant milestone in oncology and paved the way for the development of antibody-based therapies. By targeting the

Antibody-drug conjugates (ADCs) combine the specificity of monoclonal antibodies with the potent cytotoxic effects of chemotherapeutic agents. The development of ADCs traces back over a century and mirrors advancements in molecular biology and biotechnology, resulting in several approved drugs used in oncology today.

Discover the role of VHH antibodies in diagnostics & therapeutics, from viral treatments to precision diagnostics. Learn how they revolutionize antibody-based applications.

Discover the history of Muronomab (Orthoclone OKT3), the first monoclonal antibody approved by the FDA for preventing transplant rejection & its impact on immunology.

Explore the history, development, and advancements of single-chain variable fragments (scFvs), their therapeutic applications, and their evolution in antibody engineering.

Highlights from Biointron’s Lunch & Learn with MassBio: HTP antibody platforms, alpaca VHH discovery, bispecific antibodies, & ADC development advancements.

Discover the evolution of engineered antibody formats from monoclonal to bispecific antibodies, highlighting milestones in immunotherapy and clinical applications.

Explore an overview of VHH antibodies, from discovery to commercialization. Learn about their unique properties & applications in therapeutics, diagnostics & biotech!

The International Day of Women and Girls in Science, celebrated on February 11th each year, stands as a global reminder of the critical role women and girls play in science and technology communities and industries. Established by the United Nations, this day aims to promote full and equal access to and participation in science to achieve gender equality and inspire future generations to break through barriers and contribute to scientific discovery and innovation.

Discover the evolution of antibody research, from Emil von Behring's diphtheria work to hybridoma technology and modern recombinant antibody advancements.